Do you have the same question? Follow this Question
Apr 23, 2025 - 03:57 PM
We’ve provided several answers to questions related to Kenalog (Triamcinolone) , see some other helpful Q&A related to this product.
Question: Are there any drug interaction risks with the product?
Answer: Yes, there are potential drug interaction risks with oral corticosteroids like prednisone or immunosuppressants like cyclosporine. Notifying your doctor of all current medications helps prevent adverse interactions and ensures safe treatment.
Question: How should the product be applied?
Answer: The product should be rubbed onto affected skin areas twice a day or as directed by your prescription. Consistent application ensures optimal results and relief from skin inflammation and discomfort.
Question: What is the DrugBank ID for the active ingredient?
Answer: The DrugBank ID for triamcinolone is DB00620. This database provides comprehensive drug information, supporting healthcare professionals in understanding the medication's interactions, mechanisms, and applications.
Question: What is the protein binding percentage of the product?
Answer: The protein binding of the product is 68%. This percentage indicates how much of the drug binds to proteins in the bloodstream, affecting its distribution and activity duration in the body.
Question: What is the formula of the active ingredient in the product?
Answer: The formula of the active ingredient, triamcinolone, is C21H27FO6. This chemical structure is essential as it defines the properties and effectiveness of the corticosteroid in reducing inflammation and immune responses.
